Global Drugs for Herpes Labialis (Oral Herpes) Market Size, Manufacturers, Opportunities and Forecast to 2030

Global Drugs for Herpes Labialis (Oral Herpes) Market Size, Manufacturers, Opportunities and Forecast to 2030


Summary

Herpes Labialis (Oral Herpes) is a type of herpes simplex occurring on the lip, i.e. an infection caused by herpes simplex virus (HSV). An outbreak typically causes small blisters or sores on or around the mouth. The sores typically heal within 2–3 weeks, but the herpes virus remains dormant in the facial nerves, following orofacial infection, periodically reactivating (in symptomatic people) to create sores in the same area of the mouth or face at the site of the original infection.

According to APO Research, The global Drugs for Herpes Labialis (Oral Herpes) market was estimated at US$ million in 2023 and is projected to reach a revised size of US$ million by 2030, witnessing a CAGR of xx% during the forecast period 2024-2030.

North American market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Drugs for Herpes Labialis (Oral Herpes) is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global companies of Drugs for Herpes Labialis (Oral Herpes) include GSK, Novartis, Teva, Mylan, Cadila, Apotex, Daewoong Pharmaceutical, Livzon and Luoxin, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drugs for Herpes Labialis (Oral Herpes), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs for Herpes Labialis (Oral Herpes).
The Drugs for Herpes Labialis (Oral Herpes) market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drugs for Herpes Labialis (Oral Herpes) market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, gross margin by manufacturers for the period 2019-2024. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

GSK
Novartis
Teva
Mylan
Cadila
Apotex
Daewoong Pharmaceutical
Livzon
Luoxin
Med shine
Bayer (Campho Phenique)
Blistex
Kelun
Hikma
Haiwang
Carmex
Cipher
Drugs for Herpes Labialis (Oral Herpes) segment by Type

Aciclovir
Valacyclovir
Famciclovir
Docosanol
Other
Drugs for Herpes Labialis (Oral Herpes) segment by Application

External Use
Oral
Injection
Drugs for Herpes Labialis (Oral Herpes) by Distribution Channel

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drugs for Herpes Labialis (Oral Herpes) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Drugs for Herpes Labialis (Oral Herpes) and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drugs for Herpes Labialis (Oral Herpes).
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2019-2024, 2025-2030). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Drugs for Herpes Labialis (Oral Herpes) companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Region 2019 VS 2023 VS 2030
1.4 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2030)
1.4.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2019-2024)
1.4.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Region (2025-2030)
1.5 Key Regions Drugs for Herpes Labialis (Oral Herpes) Market Size (2019-2030)
1.5.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
1.5.5 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (2019-2030)
2 Drugs for Herpes Labialis (Oral Herpes) Market by Type
2.1 Type Introduction
2.1.1 Aciclovir
2.1.2 Valacyclovir
2.1.3 Famciclovir
2.1.4 Docosanol
2.1.5 Other
2.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Type
2.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Type (2019-2030)
2.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size Review by Type (2019-2024)
2.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Type (2025-2030)
2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions
2.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
2.3.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Type (2019-2024)
3 Drugs for Herpes Labialis (Oral Herpes) Market by Application
3.1 Type Introduction
3.1.1 External Use
3.1.2 Oral
3.1.3 Injection
3.2 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Application
3.2.1 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Overview by Application (2019-2030)
3.2.2 Global Drugs for Herpes Labialis (Oral Herpes) Historic Market Size Review by Application (2019-2024)
3.2.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size Forecasted by Application (2025-2030)
3.3 Global Drugs for Herpes Labialis (Oral Herpes) Market Size by Regions
3.3.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.4 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
3.3.5 Middle East and Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Breakdown by Application (2019-2024)
4 Global Market Dynamics
4.1 Drugs for Herpes Labialis (Oral Herpes) Industry Trends
4.2 Drugs for Herpes Labialis (Oral Herpes) Industry Drivers
4.3 Drugs for Herpes Labialis (Oral Herpes) Industry Opportunities and Challenges
4.4 Drugs for Herpes Labialis (Oral Herpes) Industry Restraints
5 Competitive Insights by Company
5.1 Global Top Players by Drugs for Herpes Labialis (Oral Herpes) Revenue (2019-2024)
5.2 Global Drugs for Herpes Labialis (Oral Herpes) Industry Company Ranking, 2022 VS 2023 VS 2024
5.3 Global Drugs for Herpes Labialis (Oral Herpes) Key Company Headquarters & Area Served
5.4 Global Drugs for Herpes Labialis (Oral Herpes) Company, Product Type & Application
5.5 Global Drugs for Herpes Labialis (Oral Herpes) Company Commercialization Time
5.6 Market Competitive Analysis
5.6.1 Global Drugs for Herpes Labialis (Oral Herpes) Market CR5 and HHI
5.6.2 Global Top 5 and 10 Drugs for Herpes Labialis (Oral Herpes) Players Market Share by Revenue in 2023
5.6.3 2023 Drugs for Herpes Labialis (Oral Herpes) Tier 1, Tier 2, and Tier 3
6 Company Profiles
6.1 GSK
6.1.1 GSK Comapny Information
6.1.2 GSK Business Overview
6.1.3 GSK Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.1.4 GSK Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.1.5 GSK Recent Developments
6.2 Novartis
6.2.1 Novartis Comapny Information
6.2.2 Novartis Business Overview
6.2.3 Novartis Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.2.4 Novartis Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.2.5 Novartis Recent Developments
6.3 Teva
6.3.1 Teva Comapny Information
6.3.2 Teva Business Overview
6.3.3 Teva Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.3.4 Teva Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.3.5 Teva Recent Developments
6.4 Mylan
6.4.1 Mylan Comapny Information
6.4.2 Mylan Business Overview
6.4.3 Mylan Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.4.4 Mylan Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.4.5 Mylan Recent Developments
6.5 Cadila
6.5.1 Cadila Comapny Information
6.5.2 Cadila Business Overview
6.5.3 Cadila Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.5.4 Cadila Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.5.5 Cadila Recent Developments
6.6 Apotex
6.6.1 Apotex Comapny Information
6.6.2 Apotex Business Overview
6.6.3 Apotex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.6.4 Apotex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.6.5 Apotex Recent Developments
6.7 Daewoong Pharmaceutical
6.7.1 Daewoong Pharmaceutical Comapny Information
6.7.2 Daewoong Pharmaceutical Business Overview
6.7.3 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.7.4 Daewoong Pharmaceutical Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.7.5 Daewoong Pharmaceutical Recent Developments
6.8 Livzon
6.8.1 Livzon Comapny Information
6.8.2 Livzon Business Overview
6.8.3 Livzon Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.8.4 Livzon Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.8.5 Livzon Recent Developments
6.9 Luoxin
6.9.1 Luoxin Comapny Information
6.9.2 Luoxin Business Overview
6.9.3 Luoxin Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.9.4 Luoxin Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.9.5 Luoxin Recent Developments
6.10 Med shine
6.10.1 Med shine Comapny Information
6.10.2 Med shine Business Overview
6.10.3 Med shine Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.10.4 Med shine Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.10.5 Med shine Recent Developments
6.11 Bayer (Campho Phenique)
6.11.1 Bayer (Campho Phenique) Comapny Information
6.11.2 Bayer (Campho Phenique) Business Overview
6.11.3 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.11.4 Bayer (Campho Phenique) Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.11.5 Bayer (Campho Phenique) Recent Developments
6.12 Blistex
6.12.1 Blistex Comapny Information
6.12.2 Blistex Business Overview
6.12.3 Blistex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.12.4 Blistex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.12.5 Blistex Recent Developments
6.13 Kelun
6.13.1 Kelun Comapny Information
6.13.2 Kelun Business Overview
6.13.3 Kelun Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.13.4 Kelun Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.13.5 Kelun Recent Developments
6.14 Hikma
6.14.1 Hikma Comapny Information
6.14.2 Hikma Business Overview
6.14.3 Hikma Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.14.4 Hikma Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.14.5 Hikma Recent Developments
6.15 Haiwang
6.15.1 Haiwang Comapny Information
6.15.2 Haiwang Business Overview
6.15.3 Haiwang Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.15.4 Haiwang Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.15.5 Haiwang Recent Developments
6.16 Carmex
6.16.1 Carmex Comapny Information
6.16.2 Carmex Business Overview
6.16.3 Carmex Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.16.4 Carmex Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.16.5 Carmex Recent Developments
6.17 Cipher
6.17.1 Cipher Comapny Information
6.17.2 Cipher Business Overview
6.17.3 Cipher Drugs for Herpes Labialis (Oral Herpes) Revenue, Global Share and Gross Margin (2019-2024)
6.17.4 Cipher Drugs for Herpes Labialis (Oral Herpes) Product Portfolio
6.17.5 Cipher Recent Developments
7 North America
7.1 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
7.2 North America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
7.3 North America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
8 Europe
8.1 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
8.2 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
8.3 Europe Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
9 Asia-Pacific
9.1 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
9.2 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
9.3 Asia-Pacific Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
10 Latin America
10.1 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
10.2 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
10.3 Latin America Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
11 Middle East & Africa
11.1 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Growth Rate (CAGR) by Country: 2019 VS 2023 VS 2030
11.2 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size by Country (2019-2024)
11.3 Middle East & Africa Drugs for Herpes Labialis (Oral Herpes) Market Size Forecast by Country (2025-2030)
12 Concluding Insights
13 Appendix
13.1 Reasons for Doing This Study
13.2 Research Methodology
13.3 Research Process
13.4 Authors List of This Report
13.5 Data Source
13.5.1 Secondary Sources
13.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings